Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Sanliurfa Mehmet Akif Inan Education and Research Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Turkey register with Sanliurfa Mehmet Akif Inan Education and Research Hospital as lead sponsor. Synced 19 Nov 2026
6Current trials
4Recruiting now
0Drugs in these trials
1Trial register
At a glance

Sanliurfa Mehmet Akif Inan Education and Research Hospital is the lead sponsor of 6 current clinical trials in our Turkey register. 4 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Spinal Anesthesia.

ClinicalTrials.gov trials by status

  • Recruiting467%
  • Active, closed233%

Trials by phase

  • Not applicable350%
  • Observational350%
01

Clinical trials sponsored by Sanliurfa Mehmet Akif Inan Education and Research Hospital

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Comparison Of The Effects Of Regional Anesthesia On Brain And Carotid Artery Oxygenation In Shoulder Surgery
NCT07398352 · ClinicalTrials.gov ↗ · Interscalene Block, Superficial Cervical Block, Cerebral Perfusion
Not applicable Recruiting 2026-02 Turkey
Breast and Vascular Effects of Menopausal Hormone Therapy in Postmenopausal Women
NCT07810959 · ClinicalTrials.gov ↗ · Menopause
Observational Recruiting 2026-06 Turkey
The Effect of Preoperative Anxiety Level on Vasovagal Events During Spinal Anesthesia and the Incidence of Vasovagal Events
NCT07450014 · ClinicalTrials.gov ↗ · Spinal Anesthesia, Anxiety
Observational Recruiting 2026-04 Turkey
Effect of Anterior Iliac Block on Postoperative Analgesia and Patient Satisfaction in Inguinal Hernia Repair Surgery
NCT07533383 · ClinicalTrials.gov ↗ · Anterior Ilıac Block, Hernia Surgery, Spinal Anesthesia
Not applicable Recruiting 2026-04 Turkey
Investigation of the Effects of Two Different Anaesthesia Methods Applied to Patients Scheduled for Arthroscopic Knee Surgery on the Heart
NCT07423754 · ClinicalTrials.gov ↗ · Knee Arthroscopy, Spinal Anaesthesia, Lumbar/Sciatic Block
Not applicable Active, closed 2025-09 Turkey
AI-Assisted 2D Fetal Brain Ultrasound for Intracranial Anomaly Detection
NCT07261618 · ClinicalTrials.gov ↗ · Intracranial Anomalies, Ultrasound Imaging, Artificial Intelligence
Observational Active, closed 2025-10 Turkey

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Sanliurfa Mehmet Akif Inan Education and Research Hospital trials

15 conditions
Spinal Anesthesia2Interscalene Block1Superficial Cervical Block1Cerebral Perfusion1Shoulder Surgeries1Menopause1Anxiety1Anterior Ilıac Block1Hernia Surgery1Knee Arthroscopy1Spinal Anaesthesia1Lumbar/Sciatic Block1Intracranial Anomalies1Ultrasound Imaging1Artificial Intelligence1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Turkey64

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Spinal Anesthesia

SponsorTrials
Kayseri City Hospital1

Sponsors with the most current trials registered for this condition.

05

Questions about Sanliurfa Mehmet Akif Inan Education and Research Hospital trials

How many clinical trials does Sanliurfa Mehmet Akif Inan Education and Research Hospital sponsor?

Sanliurfa Mehmet Akif Inan Education and Research Hospital is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Turkey register, as of the registry sync on 19 November 2026. Completed and withdrawn studies are not counted.

Are Sanliurfa Mehmet Akif Inan Education and Research Hospital trials recruiting?

Yes. 4 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.